Janesville, Wisconsin’s SHINE Medical Technologies LLC, announced it has secured an additional $50 million in capital financing from Oaktree Capital Management of Los Angeles. Having raised over $200 million from investors and grants, SHINE broke ground on its new facility in May of this year and expects to be producing Mo-99 in 2022. The company forecasts this facility will meet as much as one third of the world’s requirement for Mo-99.